Stock PAHC PHIBRO ANIMAL HEALTH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Phibro Animal Health Corporation

Equities

PAHC

US71742Q1067

Real-time Estimate Cboe BZX
Other stock markets
 01:13:03 2024-06-03 pm EDT 		5-day change 1st Jan Change
17.7 USD +0.37% Intraday chart for Phibro Animal Health Corporation -1.69% +53.15%
May. 09 Transcript : Phibro Animal Health Corporation, Q3 2024 Earnings Call, May 09, 2024
May. 08 Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, vs. Street Est of $0.29 MT

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Morgan Stanley Trims Price Target on Phibro Animal Health to $16 From $17, Maintains Equalweight Rating
MT
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $17 From $18, Maintains Equal-Weight Rating
MT
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $18 From $19, Maintains Equal-Weight Rating
MT
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $19 From $20, Maintains Equal-Weight Rating
MT
Roth Capital Initiates Phibro Animal Health With Buy Rating, Price Target is $18
MT
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $20 From $21, Maintains Equalweight Rating
MT
Barclays Adjusts Price Target on Phibro Animal Health to $17 From $22, Reiterates Underweight Rating
MT
Morgan Stanley Trims Price Target on Phibro Animal Health to $21 From $23, Keeps Equalweight Rating
MT
Barclays Downgrades Phibro Animal Health to Underweight From Equalweight, Price Target at $22
MT
North American Morning Briefing : Inflation, Rate -3-
DJ
Barclays Upgrades Phibro Animal Health to Equalweight from Underweight, Keeps $23 Price Target
MT
Morgan Stanley Starts Phibro Animal Health at Equal-Weight With $23 Price Target
MT
PHIBRO ANIMAL HEALTH : Barclays Downgrades Phibro Animal Health to Underweight From Equal-Weight; Price Target is $23
MT
PHIBRO ANIMAL HEALTH : Morgan Stanley Adjusts Price Target on Phibro Animal Health to $22 From $19, Maintains Underweight Rating
MT
PHIBRO ANIMAL HEALTH : Credit Suisse Raises Phibro Animal Health's Price Target to $25 from $23, Keeps Neutral Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PAHC Stock
  4. News Phibro Animal Health Corporation
  5. Analyst Reco.